Literature DB >> 27279794

Longitudinal Associations between Triglycerides and Metabolic Syndrome Components in a Beijing Adult Population, 2007-2012.

Li-Xin Tao1, Kun Yang1, Xiang-Tong Liu1, Kai Cao1, Hui-Ping Zhu1, Yan-Xia Luo1, Jin Guo1, Li-Juan Wu1, Xia Li2, Xiu-Hua Guo1.   

Abstract

BACKGROUND: Longitudinal associations between triglycerides (TG) and other metabolic syndrome (MetS) components have rarely been reported. The purpose was to investigate the longitudinal association between TG and other MetS components with time.
METHODS: The longitudinal study was established in 2007 on individuals who attended health check-ups at Beijing Tongren Hospital and Beijing Xiaotangshan Hospital. Data used in this study was based on 7489 participants who had at least three health check-ups over a period of 5-year follow up. Joint model was used to explore longitudinal associations between TG and other MetS components after adjusted for age.
RESULTS: There were positive correlations between TG and other MetS components except for high density lipoprotein (HDL), and the correlations increased with time. A negative correlation was displayed between TG and HDL, and the correlation also increased with time. Among all five pairs of TG and other MetS components, the marginal correlation between TG and body mass index (BMI) was the largest for both men and women. The marginal correlation between TG and fasting plasma glucose was the smallest for men, while the marginal correlation between TG and diastolic blood pressure was the smallest for women.
CONCLUSIONS: The longitudinal association between TG and other MetS components increased with time. Among five pairs of TG and other MetS components, the longitudinal correlation between TG and BMI was the largest. It is important to closely monitor subjects with high levels of TG and BMI in health check-up population especially for women, because these two components are closely associated with development of hypertension, diabetes, cardiovascular disease and other metabolic diseases.

Entities:  

Keywords:  Joint model; Longitudinal correlation; Metabolic syndrome components; Triglycerides

Mesh:

Substances:

Year:  2016        PMID: 27279794      PMCID: PMC4893559          DOI: 10.7150/ijms.14256

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

Metabolic syndrome (MetS) refers to a group of inter-related risk factors that include hyperglycemia, elevated blood pressure (BP), elevated triglycerides (TG), low high-density lipoprotein (HDL) levels, and obesity (in particular, central obesity) 1. MetS is a strong predictor of cardiovascular disease (CVD), diabetes, stroke, and all-cause mortality, and is becoming a major public-health challenge worldwide 2-6. Although, it is not yet clear whether MetS has a single cause, it is acknowledged that the most critical pathophysiology is insulin resistance 7, 8, and therefore the importance of central obesity was established 9. Hypertriglyceridemia is often observed in subjects with MetS, type 2 diabetes, stroke, or combined with hyperlipidemia 10, 11. The level of TG is an independent risk factor for CVD events, independent of serum HDL or low-density lipoprotein (LDL) levels 12. A number of meta-analyses have been published demonstrating associations between TG levels and CVD risk, independent of HDL level 13, 14. There are several cross-sectional studies regarding the association between TG and other MetS components. In a cross sectional survey study on 266 Turkish elderly aged people, TG was reported to be significantly correlated with weight, body mass index (BMI), waist circumference (WC), waist/hip and waist/height 15. In another study involving healthy Japanese women, high level of TG was also associated with increased level of BMI 16. Other two studies have also recognized positive correlation between TG and other metabolic risk factors using partial correlation analysis and pearson correlation analysis 17, 18. However, there have been limited data about longitudinal associations between TG and other MetS components. To fully understand the longitudinal association between TG and other MetS components, longitudinal studies are required, especially using repeated measures of MetS components. Therefore, the aim of the present study was to assess longitudinal associations between TG and other MetS components in a Beijing adult population from 2007 to 2012.

Methods

Participants

The longitudinal study was set up in 2007 on adults who attended health check-ups at Beijing Tongren Hospital and Beijing Xiaotangshan Hospital. A total of 7489 subjects with at least three health check-ups in the 5-year follow-up were enrolled in the study. Individuals with a previous diagnosis of CVD, cerebral infarction, gastric cancer, or those who had undergone coronary artery bypass surgery, coronary stenting surgery or gastrectomy, or those who had MetS, obesity, dyslipidemia, hyperglycemia, or hypertension at baseline were excluded. The study was approved by the ethics committee of Capital Medical University of China, and performed in accordance with the principles of Declaration of Helsinki (2013SY26). All participants gave their informed written consents.

Definition of MetS

MetS was diagnosed if participants had three or more of the following risk determinants according to the Joint Interim Statement criteria 1. However, WC was not measured because of limited health check-up site, and BMI was taken as a substitute for the component of obesity 19. The determinants were as follows: Obesity: BMI ≥ 28 kg/m²; Elevated TG (drug treatment for elevated TG is an alternate indicator) ≥ 150 mg/dL (1.7 mmol/L); Reduced HDL (drug treatment for reduced HDL is an alternate indicator) < 40 mg/dL (1.0 mmol/L) in males, < 50 mg/dL (1.3 mmol/L) in females; Elevated BP (antihypertensive drug treatment in a patient with a history of hypertension is an alternate indicator) systolic blood pressure (SBP) ≥ 130 mmHg and/or diastolic blood pressure (DBP) ≥ 85 mmHg; Elevated fasting plasma glucose (FPG) (drug treatment of elevated glucose is an alternate indicator) ≥ 100 mg/dL.

Measurements

The participants underwent routine physical examinations that included the measurement of height, weight, BP, and overnight fasting blood sampling. Weight and height were measured without shoes, and BMI was calculated as weight (kg) divided by squared height (m). The measurement of weight was undergone at least twice for the improvement of reliability. The intra variability of weight was < 5%. BP was measured on the right upper arm and maintained at the level of the heart with participants in sitting position. BP was measured by trained and certified nurses working in Beijing Tongren Hospital and Beijing Xiaotangshan Hospital. Before measuring BP, subjects were at rest for at least 5 minutes. The trained nurse will measure BP three times in the following 30 minutes. During the 30 min preceding the measurements, the subjects were required to refrain from smoking or consuming caffeine. A standard mercury sphygmomanometer was used with 1 of 4 cuff sizes (pediatric, regular adult, large adult, or thigh) based on the participant's arm circumference. Three readings of SBP and DBP were recorded, and the average of the last two measurements was used for data analysis. Blood samples were obtained from antecubital vein into tubes containing ethylenediaminetetraacetic acid (EDTA) in the morning after an overnight fasting period. Then the samples were stored in 4°C refrigerator, and they will be analyzed in 8 hours. HDL, TG, and FPG were measured by enzymatic method using a chemistry analyzer (Beckman LX 20, America) at Department of Clinical Laboratory in Beijing Tongren Hospital and Beijing Xiaotangshan Hospital. All analyses performed in accordance with the manufacturer's recommendations.

Statistical Analysis

Missing Data Imputation and Data analysis

To account for missing values, multiple imputation (MI) was performed. Because the imputation method of choice depended on the pattern of missing data and the type of the imputed variables, the Markov Chain Monte Carlo method was chosen to avoid loss of generality. The MI procedure of SAS software package (version 9.2; SAS Institute, Chicago, IL, USA) was used 20. Data were expressed as mean ± standard deviation or, for non-normally distributed variables, as median and interquartile range. To compare the differences between groups, student's t test or Wilcoxon rank sum test was used to determine differences between groups. Joint model was conducted using SAS mixed procedure to account for longitudinal correlations between TG and other MetS components. Data were analyzed using SAS software package and P < 0.05 was considered as significant. When there were two continuous response variables, Y and Y, they were measured over time for a number of subjects. Each of the variables was described using the linear mixed-effects model: The marginal correlation between Y1 and Y2 at time t is given by:

Results

Basic characteristics and MetS components of the subjects

The basic characteristics and MetS components of the study population in 2007 and 2012 were shown in Table 1. There were 7489 individuals included in the study in 2007 at baseline (3389 men, 41.55±10.81 years; 4100 women, 41.03±10.24 years). Significant differences were displayed in the levels of age, BMI, FPG, HDL, SBP, DBP, and TG between men and women.
Table 1

Basic characteristics and MetS components of subjects in 2007 and 2012

YearVariablesMenWomentP
2007N33894100--
age41.55±10.8141.03±10.24-2.130.0332
BMI (kg/m2)23.42±2.5021.80±2.53-27.88<0.0001
FPG (mmol/L)4.88±0.424.86±0.40-2.120.0341
HDL (mmol/L)1.35±0.271.63±0.3043.27<0.0001
SBP (mmHg)111.25±9.11105.94±10.43-23.49<0.0001
DBP (mmHg)73.72±6.5869.87±7.42-23.76<0.0001
TG (mmol/L)1.04±0.350.85±0.34-24.62<0.0001
2012N17442171--
BMI (kg/m2)24.26±2.7022.45±2.81-20.36<0.0001
FPG (mmol/L)5.16±0.535.05±0.45-6.94<0.0001
HDL (mmol/L)1.27±0.281.57±0.3330.61<0.0001
SBP (mmHg)119.58±13.32113.24±14.33-14.31<0.0001
DBP (mmHg)73.03±9.8069.56±9.71-11.08<0.0001
TG (mmol/L)1.33±0.741.04±0.53-14.06<0.0001

Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; TG = triglycerides.

-: Test was not performed on sample size (n).

Results of Joint Model

Fixed-effects tests for age are displayed in Table 2. It was indicated that age had significant effects on the development of TG, BMI, FPG, SBP and DBP for men. And age had significant effects on the development of all MetS components for women.
Table 2

Fixed-Effects Tests of age for all subjects

Pairs of MetS componentsOutcomeMenWomen
t#p#t#p#
TG and BMITG7.73<0.000120.79<0.0001
BMI7.62<0.000124.28<0.0001
TG and FPGTG7.30<0.000120.70<0.0001
FPG6.40<0.00013.93<0.0001
TG and HDLTG8.46<0.000122.17<0.0001
HDL1.890.0582-2.720.0066
TG and SBPTG7.43<0.000117.07<0.0001
SBP11.55<0.000124.20<0.0001
TG and DBPDBP13.80<0.000121.46<0.0001
TG7.23<0.000120.73<0.0001

Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; TG = triglycerides.

#: Joint Model was used.

The marginal correlations between TG and other MetS components after adjusted for age are presented in Table 3, Figure 1 and Figure 2.
Table 3

The marginal correlation between TG and other MetS components for all subjects

Pairs of MetS components200720082009201020112012
MenTG and BMI*0.24230.24330.25710.27920.30600.3350
TG and FPG*0.06540.06490.07770.09800.12130.1450
TG and HDL*-0.1583-0.1682-0.1891-0.2173-0.2500-0.2848
TG and SBP*0.08300.09730.11700.13910.16160.1832
TG and DBP*0.09590.10920.12820.14950.17100.1915
WomenTG and BMI*0.21400.39190.47930.52350.54790.5624
TG and FPG*0.06960.15180.19670.22010.23310.2409
TG and HDL*-0.1708-0.3429-0.4312-0.4765-0.5016-0.5166
TG and SBP*0.09270.22180.30000.34260.36680.3814
TG and DBP*0.08180.09090.10510.12270.14210.1621

Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; TG = triglycerides.

*: P<0.001

Figure 1

The marginal correlations between TG and other MetS components for men. Abbreviations: BMI = body mass index; FPG = fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; TG = triglycerides; MetS = metabolic syndrome.

Figure 2

The marginal correlations between TG and other MetS components for women. Abbreviations: BMI = body mass index; FPG = fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure; TG = triglycerides; MetS = metabolic syndrome.

Longitudinal correlations between TG and other MetS components for men adjusted for age were presented in Figure 1. There were positive correlations between TG and other MetS components except for HDL, and the correlations gradually increased with time. A negative correlation was displayed between TG and HDL, and the correlation also increased with time. Among all five pairs of TG and other MetS components, the marginal correlation between TG and BMI was the largest, and the marginal correlation between TG and FPG was the smallest. Longitudinal correlations between TG and other MetS components for women adjusted for age were displayed in Figure 2. Positive associations were detected between TG and other MetS components except for HDL, and the correlations increased rapidly with time. TG was negatively correlated with HDL, and the correlation also increased with time. Among all the five cases, the marginal correlation between TG and BMI was the largest, and the marginal correlation between TG and DBP was the smallest.

Discussion

Longitudinal associations between TG and other MetS components over time have rarely been considered in previous studies. Joint model is a novel method detecting longitudinal association between two outcomes. Joint modeling two MetS components, rather than modeling them independently, and therefore incorporates additional information into the model that may increase estimation and prediction accuracy. Joint model has often been applied for longitudinal measurements and time-to-event data 21, 22. The model also has been used for two longitudinal continuous measurements. One previous study using the joint model detected a very strong association between the development of two hearing thresholds and a slowly increasing change in the association between these thresholds over time 23. However, there are few inferences about using the joint model to analyze the longitudinal association between TG and other MetS components with time. In the present study, longitudinal associations between TG and other MetS components were assessed after adjusted for age. It was suggested that the marginal correlation between TG and BMI was the largest and the correlation increased with time for both men and women. And the correlation between TG and BMI is larger for women than men. The positive association was also reported in previous literature using partial correlation analysis in a cross sectional study 17. But no inference has shown the longitudinal association between TG and BMI. Positive association between TG and BMI was also detected in the present study, as shown previously 19, 24. Therefore, it is important to closely monitor subjects with high levels of TG and BMI especially for women, because these two components are closely associated with development of hypertension, diabetes, CVD and other chronic diseases. The marginal correlation between TG and FPG was positive and increased with time for men and women. But the correlation between TG and FPG is larger for women than men. Previous literatures have suggested that individuals with elevated FPG usually have a number of other metabolic abnormalities, including elevated TG, and elevated BP 24-26. It has been reported that lipotoxicity by deposition of TG may be associated with beta-cell dysfunction and insulin resistance 27. The marginal correlation between TG and HDL increased with time for both genders. The correlation between TG and HDL was extremely larger for men than women. The strong association between TG and HDL were consistent with previous results 25, 28, 29. One study has shown that an increase in TG level is commonly associated with a reduction in HDL level 30. It has been indicated that hypertriglyceridemia stimulates the enzymatic activity of cholesterol ester transfer protein, which facilitates the transfer of TG from TG-rich lipoproteins to HDL and LDL in exchange for cholesteryl esters 31. This leads to an increase in TG content of HDL and LDL. The marginal correlation between TG and BP increased slowly with time for men and women in the present study. The correlation between TG and SBP was a little larger for women than men. But the correlation between TG and DBP for men was slightly larger for men than women. One previous study has shown a significant increase in plasma TG level as BP levels increased from optimally normal, across high-normal to hypertensive levels 32. The strength of this research was that it was a longitudinal study of 5 years in a Beijing adult population. The present study assessed longitudinal association between TG and other MetS components for the first time. The limitation was the lack of WC as an indicator for central obesity, however, BMI was used for substitute. One study showed that the two measures of BMI and WC are closely correlated 33. Another study indicated that most individuals with an abnormal BMI also have an abnormal WC. Both indexes of excess adiposity are positively associated with SBP, FPG, and TG and inversely associated with HDL 34. One study based on a cross-sectional field survey targeted adults in China demonstrated that dyslipidemia, particularly hypertriglyceridemia and low HDL is associated with central obesity (measured with WC) using multivariate logistic regression 35. A previous study used both BMI and WC has shown that either of the two measures can be recommended in screening for MetS in routine clinical practice in order to combat CVD and type 2 diabetes 36. In addition, this study was based on an adult population of health check-up. This limits the generalizability of the data to other populations to some extent. Further studies using the general population would be desirable.

Conclusions

The present study assessed longitudinal association between TG and other MetS components for the first time. The longitudinal association between TG and other MetS components increased with time. Among five pairs of TG and other MetS components, the correlation between TG and BMI was the largest. The correlation between TG and FPG was the smallest for men, while the correlation between TG and DBP was the smallest for women. It is important to closely monitor subjects with high levels of TG and BMI in health check-up population especially for women, because these two components are closely associated with development of hypertension, diabetes, CVD, and other chronic diseases.
  36 in total

1.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

2.  Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.

Authors:  M Guérin; W Le Goff ; T S Lassel; A Van Tol ; G Steiner; M J Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

3.  Body mass index, waist circumference, and cardiometabolic risk factors in young and middle-aged Chinese women.

Authors:  Xin Ying; Zhen-ya Song; Chang-jun Zhao; Yan Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

4.  Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study.

Authors:  Mi Hae Seo; Ji Cheol Bae; Se Eun Park; Eun Jung Rhee; Cheol Young Park; Ki Won Oh; Sung Woo Park; Sun Woo Kim; Won-Young Lee
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

5.  Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population.

Authors:  Erfan Ayubi; Davood Khalili; Ali Delpisheh; Farzad Hadaegh; Fereidoun Azizi
Journal:  J Diabetes       Date:  2015-02-19       Impact factor: 4.006

6.  Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.

Authors:  Jacob A Udell; Ph Gabriel Steg; Benjamin M Scirica; Kim A Eagle; E Magnus Ohman; Shinya Goto; Alawi A Alsheikh-Ali; Avi Porath; Ramon Corbalan; Amarachi A Umez-Eronini; Elaine B Hoffman; Peter W F Wilson; Deepak L Bhatt
Journal:  Eur J Prev Cardiol       Date:  2013-08-05       Impact factor: 7.804

7.  Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study.

Authors:  Ki-Chul C Sung; Mi-Hae H Seo; Eun-Jung J Rhee; Andrew M Wilson
Journal:  Cardiovasc Diabetol       Date:  2011-11-30       Impact factor: 9.951

8.  Plasma lipid profile in Nigerians with high--normal blood pressure.

Authors:  Hadiza Saidu; Kamilu Musa Karaye; Basil N Okeahialam
Journal:  BMC Res Notes       Date:  2014-12-18

9.  Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions.

Authors:  Bishwajit Bhowmik; Faria Afsana; Tasnima Siddiquee; Sanjida B Munir; Fareeha Sheikh; Erica Wright; Farjana R Bhuiyan; Sheikh Mohammad Ashrafuzzaman; Hajera Mahtab; Abul Kalam Azad Khan; Akhtar Hussain
Journal:  J Diabetes Investig       Date:  2014-08-25       Impact factor: 4.232

10.  Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease.

Authors:  Alexander Vonbank; Christoph H Saely; Philipp Rein; Heinz Drexel
Journal:  Cardiovasc Diabetol       Date:  2013-07-17       Impact factor: 9.951

View more
  7 in total

1.  Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components.

Authors:  G J Ooi; L Doyle; T Tie; J M Wentworth; C Laurie; A Earnest; M A Cowley; K Sikaris; C W le Roux; P R Burton; P E O'Brien; W A Brown
Journal:  Int J Obes (Lond)       Date:  2017-03-06       Impact factor: 5.095

2.  Lipocalin 2 deficiency-induced gut microbiota dysbiosis evokes metabolic syndrome in aged mice.

Authors:  Vishal Singh; Sarah Galla; Rachel M Golonka; Andrew D Patterson; Benoit Chassaing; Bina Joe; Matam Vijay-Kumar
Journal:  Physiol Genomics       Date:  2020-07-06       Impact factor: 3.107

3.  Total Testosterone to Estradiol Ratio as a Predictor Marker of Metabolic Syndrome in Males.

Authors:  M Ali Hamza; A Abdulhameed; A Ali Mansour
Journal:  Arch Razi Inst       Date:  2022-02-28

4.  Multiple metabolic pathways are predictive of ricin intoxication in a rat model.

Authors:  Riccardo V D'Elia; Sarah A Goodchild; Catherine L Winder; Andrew D Southam; Ralf J M Weber; Fiona M Stahl; Cerys Docx; Vikesh Patel; A Christopher Green; Mark R Viant; Roman A Lukaszewski; Warwick B Dunn
Journal:  Metabolomics       Date:  2019-07-03       Impact factor: 4.290

5.  Factors associated with hypertriglyceridemia among the hill tribe people aged 30 years and over, Thailand: a cross-sectional study.

Authors:  Panupong Upala; Tawatchai Apidechkul; Chanyanut Wongfu; Siriyaporn Khunthason; Niwed Kullawong; Vivat Keawdounglek; Chalitar Chomchoei; Fartima Yeemard; Ratipark Tamornpark
Journal:  BMC Public Health       Date:  2021-03-23       Impact factor: 3.295

6.  Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.

Authors:  Xiao-Rong Wang; Gui-Rong Song; Meng Li; Hong-Ge Sun; Yong-Jun Fan; Ying Liu; Qi-Gui Liu
Journal:  BMJ Open       Date:  2018-05-09       Impact factor: 2.692

7.  Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria.

Authors:  Mieke Van Hemelrijck; Hanno Ulmer; Gabriele Nagel; Raphael Simon Peter; Josef Fritz; Robin Myte; Bethany van Guelpen; Bernhard Föger; Hans Concin; Christel Häggström; Pär Stattin; Tanja Stocks
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.